Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-004599
Filing Date
2015-12-22
Accepted
2015-12-22 13:32:57
Documents
30
Period of Report
2015-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q odyssey_10q-103115.htm 10-Q 205272
2 CONSENT odyssey_10q-2301.htm EX-23.1 2030
3 CERTIFICATION odyssey_ex3101.htm EX-31.1 8387
4 CERTIFICATION odyssey_ex3201.htm EX-32.1 3577
  Complete submission text file 0001019687-15-004599.txt   709504

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE none-20151031.xml EX-101.INS 35516
6 XBRL SCHEMA FILE none-20151031.xsd EX-101.SCH 9575
7 XBRL CALCULATION FILE none-20151031_cal.xml EX-101.CAL 18731
8 XBRL DEFINITION FILE none-20151031_def.xml EX-101.DEF 11909
9 XBRL LABEL FILE none-20151031_lab.xml EX-101.LAB 70549
10 XBRL PRESENTATION FILE none-20151031_pre.xml EX-101.PRE 49359
Mailing Address 4262 BLUE DIAMOND ROAD, SUITE 102-281 LAS VEGAS NV 89139
Business Address 4262 BLUE DIAMOND ROAD, SUITE 102-281 LAS VEGAS NV 89139 702-751-1418
Odyssey Group International, Inc. (Filer) CIK: 0001626644 (see all company filings)

EIN.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-200785 | Film No.: 151301581
SIC: 2833 Medicinal Chemicals & Botanical Products